Impact BioMedical Inc (AMEX: IBO) is -58.62% lower on its value in year-to-date trading and has touched a low of $0.37 and a high of $6.17 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBO stock was last observed hovering at around $0.75 in the last trading session, with the day’s loss setting it -0.15%.
Currently trading at $0.60, the stock is 19.72% and -44.64% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.48 million and changing -19.79% at the moment leaves the stock -65.36% off its SMA200. IBO registered a loss of -72.85% in past 6-months.
The stock witnessed a 29.31% gain in the last 1 month and extending the period to 3 months gives it a -60.78%, and is 36.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 29.09% over the week and 21.31% over the month.
Impact BioMedical Inc (IBO) has around 2 employees, a market worth around $6.90M and $0.00M in sales. Distance from 52-week low is 62.16% and -90.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-580.23%).
.
Impact BioMedical Inc (IBO) Top Institutional Holders
13.0 institutions hold shares in Impact BioMedical Inc (IBO), with institutional investors hold 3.17% of the company’s shares. The shares outstanding are 11.50M, and float is at 10.07M with Short Float at 1.22%. Institutions hold 1.93% of the Float.
Impact BioMedical Inc (IBO) Insider Activity
The most recent transaction is an insider sale by DSS, INC., the company’s 10% Owner. SEC filings show that DSS, INC. sold 890,800 shares of the company’s common stock on Apr 04 ’25 at a price of $0.95 per share for a total of $0.85 million. Following the sale, the insider now owns 0.16 million shares.
Impact BioMedical Inc disclosed in a document filed with the SEC on Apr 03 ’25 that Chan Heng Fai Ambrose (Director) sold a total of 351,555 shares of the company’s common stock. The trade occurred on Apr 03 ’25 and was made at $0.49 per share for $0.17 million. Following the transaction, the insider now directly holds 0.0 shares of the IBO stock.
Still, SEC filings show that on Apr 02 ’25, Chan Heng Fai Ambrose (Director) disposed off 884,776 shares at an average price of $0.60 for $0.53 million. The insider now directly holds 351,555 shares of Impact BioMedical Inc (IBO).
